Clinical efficacy of lenalidomide in fludarabine-refractory chronic lymphocytic leukemia patients.

被引：4
|
作者：
Chanan-Khan, AsherA. [1 ]
Czuczman, Myron S. [1 ]
Padmanabhan, Swarminathan [1 ]
Keating, Michael J. [2 ]
O'Brien, Susan M. [2 ]
Wierda, William G. [2 ]
Ferrajoli, Alessandra [2 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY USA
[2] MD Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3108.3108
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3108
引用
收藏
页码：914A / 914A
页数：1
相关论文
共 50 条
  • [41] Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab
    Wierda, William
    Kipps, Thomas
    Mayer, Jiri
    Stilgenbauer, Stephan
    Williams, Cathy D.
    Hellmann, Andrzej
    Robak, Tadeusz
    Furman, Richard R.
    Hillmen, Peter
    Trneny, Marek
    Dyer, Martin J. S.
    Padmanabhan, Swami
    Piotrowska, Magdalena
    Kozak, Tomas
    Chan, Geoffrey
    Davis, Randy
    Losic, Nedjad
    Wilms, Joris
    Russell, Charlotte
    Osterborg, Anders
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (06): : E36 - E36
  • [42] Clinical efficacy of lenalidomide {Revlimid®} in patients with relapsed or refractory chronic lymphocytic leukemia (CLL):: Updated results of a phase II clinical trial.
    Chanan-Khan, Asher Alban
    Miller, Kena C.
    Musial, Laurie
    Padmanabhan, Swaminathan
    Lawrence, David
    Bernstein, Zale P.
    Takeshita, Kenichi
    Spaner, David
    Byrne, Catriona
    Chrystal, Cynthia
    Czuczman, Myron S.
    BLOOD, 2006, 108 (11) : 95A - 95A
  • [43] Safety and efficacy of of atumumab in patients with fludarabine and alemtuzumab refractory chronic lymphocytic leukaemia
    Dyer, Martin J. S.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (04) : 199 - 207
  • [44] IMMUNOSUPPRESSIVE EFFECTS AND CLINICAL-RESPONSE OF FLUDARABINE IN REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA
    BERGMANN, L
    FENCHEL, K
    JAHN, B
    MITROU, PS
    HOELZER, D
    ANNALS OF ONCOLOGY, 1993, 4 (05) : 371 - 375
  • [45] Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia
    Tsimberidou, AM
    Keating, MJ
    Giles, FJ
    Wierda, WG
    Ferrajoli, A
    Lerner, S
    Beran, M
    Andreeff, M
    Kantarjian, HM
    O'Brien, S
    CANCER, 2004, 100 (12) : 2583 - 2591
  • [46] Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial
    Mauro, Francesca R.
    Carella, Angelo M.
    Molica, Stefano
    Paoloni, Francesca
    Liberati, Anna M.
    Zaja, Francesco
    Belsito, Valeria
    Cortellezzi, Agostino
    Rizzi, Rita
    Tosi, Patrizia
    Spriano, Mauro
    Ferretti, Antonietta
    Nanni, Mauro
    Marinelli, Marilisa
    De Propris, Maria S.
    Orlando, Sonia M.
    Vignetti, Marco
    Cuneo, Antonio
    Guarini, Anna R.
    Foa, Robin
    LEUKEMIA & LYMPHOMA, 2017, 58 (07) : 1640 - 1647
  • [47] Correlation Between Serum Ofatumumab Concentrations, Baseline Patient Characteristics and Clinical Outcomes in Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia (CLL) Treated with Single-Agent Ofatumumab
    Osterborg, Anders
    Ronn, Birgitte Biilmann
    Jewell, Roxanne C.
    Kipps, Thomas J.
    Mayer, Jiri
    Stilgenbauer, Stephan
    Williams, Cathy D.
    Hellmann, Andrzej
    Robak, Tadeusz
    Furman, Richard R.
    Hillmen, Peter
    Trneny, Marek
    Dyer, Martin J. S.
    Padmanabhan, Swami
    Piotrowska, Magdalena
    Kozak, Tomas
    Chan, Geoffrey
    Arning, Michael
    Losic, Nedjad
    Davis, Randy
    Wilms, Joris
    Russell, Charlotte A.
    Wierda, William G.
    BLOOD, 2009, 114 (22) : 1334 - 1334
  • [48] 2-CHLORODEOXYADENOSINE THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA REFRACTORY TO FLUDARABINE
    OBRIEN, S
    KANTARJIAN, H
    ESTEY, E
    KOLLER, C
    ROBERTSON, LE
    BERAN, M
    ANDREEFF, M
    PIERCE, S
    KEATING, M
    BLOOD, 1993, 82 (10) : A141 - A141
  • [49] Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogenetics
    Sher, Taimur
    Miller, Kena C.
    Lawrence, David
    Whitworth, Amy
    Hernandez-Ilizaliturri, Francisco
    Czuczman, Myron S.
    Miller, Austin
    Lawrence, William
    Bilgram, Syed Ali
    Sood, Raman
    Wood, Margaret T.
    Block, Annemarie W.
    Lee, Kelvin
    Chanan-Khan, Asher Alban
    LEUKEMIA & LYMPHOMA, 2010, 51 (01) : 85 - 88
  • [50] Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
    Ferrajoli, Alessandra
    Lee, Bang-Ning
    Schlette, Ellen J.
    O'Brien, Susan M.
    Gao, Hui
    Wen, Sijin
    Wierda, William G.
    Estrov, Zeev
    Faderl, Stefan
    Cohen, Evan N.
    Li, Changping
    Reuben, James M.
    Keating, Michael J.
    BLOOD, 2008, 111 (11) : 5291 - 5297
12345